LAKEWOOD, Colo. – December 5, 2023 – Terumo Blood and Cell Technologies took part in Connecting the Dots, an initiative bringing together stakeholders across the cell and gene therapy ecosystem to address key challenges in manufacturing and delivering advanced therapies to patients.
The event convened industry leaders, researchers and clinicians to discuss strategies for improving the scalability, accessibility and affordability of cell and gene therapies, with a focus on connecting manufacturing innovation with patient outcomes.
"Collaboration across the entire cell and gene therapy ecosystem is essential to overcoming the manufacturing and access challenges that currently limit these transformative therapies," said a Terumo Blood and Cell Technologies representative. "We are proud to contribute our expertise to these important conversations."
Terumo Blood and Cell Technologies continues to work with partners across the industry to advance automated, scalable solutions for cell and gene therapy manufacturing.
About Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies, a Terumo group company, is a global leader committed to providing high-quality products and services for blood and blood component collection, and for the production of biotherapies, including cell and gene therapies. Together with our partners and customers, we envision and advance a world where blood and cell technologies contribute to the health and well-being of all people.
